Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, and Repligen Corporation, a global life sciences company focused on bioprocessing technologies, ...
Sartorius and Repligen launched an integrated bioreactor system that incorporates Repligen XCell ® ATF upstream intensification technology into Sartorius’ Biostat STR ® bioreactor. The goal is to ...
The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...
Sartorius Stedim Biotech (SSB) said today it will integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors to create novel perfusion ...
(MENAFN- GlobeNewsWire - Nasdaq) The perfusion bioreactors market is booming due to rising biopharmaceutical demand, innovations in bioreactor design, and regulatory support. Key opportunities include ...
MEDFORD, Mass.--(BUSINESS WIRE)--Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today ...
(MENAFN- EIN Presswire) EINPresswire/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors Perfusion Bioreactor With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback